Assessment of Quality of Life of Chronic Myeloid Leukemia Patients by Using the EORTC QLQ-C30
Journal Title: Turkish Journal of Hematology - Year 2017, Vol 34, Issue 2
Abstract
To the Editor,
Authors and Affiliations
Mehmet Can Uğur, Yaşar Bekir Kutbay, Özge Özer Kaya, Cengiz Ceylan
Keywords
Related Articles
- EP ID EP228551
- DOI 10.4274/tjh.2016.0409
- Views 112
- Downloads 0
Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia
To the Editor, The most common mechanisms for resistance in patients with chronic myeloid leukemia (CML) receiving imatinib mesylate are BCR-ABL kinase domain (KD) mutations. The mutations are stratifi ed according to i...
Blue Lunula Related with Hydroxyurea
Hydroxyurea, which is an inhibitor of ribonucleoside reductase and is used as a systemic antitumor agent, is frequently used for the treatment of myeloproliferative and hematologic diseases. While the most common side ef...
Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin’s Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group
Objective: The prognostic factors and a new childhood prognostic index after autologous hematopoietic stem cell transplantation (AHSCT) in patients with relapsed/refractory Hodgkin’s lymphoma (HL) were evaluated. Materia...
Glomerular and Tubular Functions in Transfusion-Dependent Thalassemia
.
Three Novel Calreticulin Mutations in Two Turkish Patients
.